Endocrinopathy and ectopic hormones in malignancy.
This article reports progress in the field of endocrinopathies and focuses on the molecular aspects of these diseases. Implications for genetics and metabolic study are presented. Although limitations of earlier approaches are confirmed, progress is noted, particularly with regard to the contribution of octreotide scintigraphy. Integrated with the evolving applications of molecular insights, significant clinical progress has been recorded.
Keffer
J H
JH
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, USA.
D004700:Endocrine System Diseases / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D009377:Multiple Endocrine Neoplasia / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D010257:Paraneoplastic Syndromes / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology